New method evaluates how mutations to SARS-CoV-2 can affect antibody recognition in rapid antigen tests

A research team funded by the National Institutes of Health has shown that commercially available rapid antigen tests can detect past and present variants of concern and has identified potential mutations that may impact test performance in the future.

Related Keywords

United States ,American ,Brucej Tromberg ,Filipp Frank ,Eric Ortlund ,Emily Henderson ,Emory University ,National Institutes Of Health ,National Institute Of Biomedical Imaging ,National Institutes ,National Institute ,Biomedical Imaging ,American Rescue Plan Act ,Antigen ,Cars ,Ars Cov 2 ,Amino Acid ,Antibodies ,Ntibody ,Iochemistry ,Ioengineering ,Fell ,Covid 19 ,Iagnostic ,Iagnostics ,Electron ,Maging ,Medical Research ,Micrograph ,Utation ,Micron ,Mh ,Protein ,Research ,Virus ,